Evaluation of complement factor 5 variants as genetic risk factors for the development of advanced fibrosis in chronic hepatitis C infection☆
To access this article, please choose from the options below
☆ Dr. Landt is employed by TIB MOLBIOL, Berlin, Germany. The authors declare that they do not have anything to disclose regarding funding from industries or conflict of interest with respect to this manuscript.
PII: S0168-8278(08)00371-1
doi:10.1016/j.jhep.2008.05.021
© 2008 European Association for the Study of the Liver. Published by Elsevier Inc. All rights reserved.
